Search
Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: Company News

Creeden Joins UVA Licensing & Ventures

Tuesday, October 4, 2016  
Share |
Robert J. Creeden has joined the University of Virginia’s Licensing & Ventures Group as its first managing director of the UVA Seed Fund and New Ventures.

“We are very pleased to have been able to recruit as talented a professional as Bob to UVA,” said Michael P. Straightiff, the Licensing & Ventures Group’s executive director. “We believe his extensive experience in company formation and management, early-stage investing and in commercializing new technologies will help UVA continue to grow.”

As the managing director of New Ventures, Creeden is tasked with building initiatives to identify opportunities for the creation of high-quality ventures based on new technologies in the Licensing & Ventures Group’s portfolio, recruiting talented executives and entrepreneurs-in-residence and mentoring and advising newly formed companies.

Creeden also leads the day-to-day operations of the UVA Seed Fund. The $10 million fund was created in 2015 using UVA Health System funds and unrestricted private funds to launch and support new ventures emerging from the University portfolio and to fill the “capital gap” for technologies considered too early or too small for investment by traditional sources.

“I am delighted to lead the Seed Fund and new ventures at UVA,” Creeden said. “By investing in UVA-based start-ups, the University is enhancing the impact of transformative ideas and addressing an unmet need.”

Creeden comes to the University community after serving as the founding executive director of the Blackstone Entrepreneurs Network in the North Carolina Research Triangle. His efforts helped strengthen the area’s business environment, resulting in early-stage and seed investment of more than $60 million.

In 2005, Creeden created and managed the Partners Innovation Fund at Partners HealthCare in Boston – one of the first academic medical center venture funds of its kind in the country. Prior to joining Partners, Creeden served as vice president of the Massachusetts Technology Development Corporation, an early-stage venture firm, and as general partner of Egan-Managed Capital, a $150 million New England-based venture firm.

Creeden’s career began in start-ups, where he served as chief operating officer and chief financial officer for various early-stage ventures in the Boston area.

more Events

12/8/2016
Virginia Bioscience Commercialization Luncheon- December 2016

12/12/2016 » 12/14/2016
ISBioTech 4th Fall Meeting

Premium Members

Membership Software Powered by YourMembership  ::  Legal